STIM
Neuronetics Inc
NASDAQ: STIM · HEALTHCARE · MEDICAL DEVICES
$1.94
+14.12% today
Updated 2026-04-30
Market cap
$117.59M
P/E ratio
—
P/S ratio
0.79x
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$1 – $5
Volume
1.9M
Neuronetics Inc (STIM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-8.54M | $-11.14M | $-20.59M | $-30.48M | $-28.39M | $-27.98M | $-30.74M | $-32.04M | $-31.00M | $-20.37M |
| Capital expenditures | $324000.00 | $594000.00 | $1.01M | $813000.00 | $730000.00 | $2.35M | $3.27M | $2.37M | $1.47M | $801000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $161000.00 | $496000.00 | $1.74M | $3.43M | $4.40M | $7.87M | $8.75M | $7.32M | $5.60M | $6.85M |
| Free cash flow | $-8.87M | $-11.74M | $-21.60M | $-31.30M | $-29.12M | $-30.34M | $-34.01M | $-34.41M | $-32.46M | $-21.18M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $75.44M | $-28.88M | $-26.75M | — | $-23.80M | — | — | — |